• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆蛋白S含有锌,这对于有效的不依赖活化蛋白C的抗凝活性以及与因子Xa的结合是必需的,但对于与组织因子途径抑制剂的有效结合则不是必需的。

Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

作者信息

Heeb Mary J, Prashun Duane, Griffin John H, Bouma Bonno N

机构信息

Department of Molecular and Experimental Medicine, MEM276, Scripps Research Institute, 10550 N. Torrey Pines Rd, La Jolla, CA 92037, USA.

出版信息

FASEB J. 2009 Jul;23(7):2244-53. doi: 10.1096/fj.08-123174. Epub 2009 Feb 24.

DOI:10.1096/fj.08-123174
PMID:19244162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2704590/
Abstract

Protein S (PS) is a cofactor for activated protein C (APC), which inactivates coagulation factors (F) Va and VIIIa. Deficiency of protein C or PS is associated with risk of thrombosis. We found that PS also has APC-independent anticoagulant activity (PS-direct) and directly inhibits thrombin generated by FXa/FVa (prothrombinase complex). Here we report that PS contains Zn(2+) that is required for PS-direct and that is lost during certain purification procedures. Immunoaffinity-purified PS contained 1.4 +/- 0.6 Zn(2+)/mol, whereas MonoQ-purified and commercial PS contained 0.15 +/- 0.15 Zn(2+)/mol. This may explain the controversy regarding the validity of PS-direct. Zn(2+) content correlated positively with PS-direct in prothrombinase assays and clotting assays, but APC-cofactor activity of PS was independent of Zn(2+) content. PS-direct and Zn(2+) were restored to inactive PS under mildly denaturing conditions. Conversely, o-phenanthroline reversibly impaired the PS-direct of active PS. Zn(2+)-containing PS bound FXa more efficiently (K(d)(app)=9.3 nM) than Zn(2+)-deficient PS (K(d)(app)=110 nM). PS bound TFPI efficiently, independently of Zn(2+) content (K(d)(app)=21 nM). Antibodies that block PS-direct preferentially recognized Zn(2+)-containing PS, suggesting conformation differences at or near the interface of 2 laminin G-like domains near the PS C terminus. Thus, Zn(2+) is required for PS-direct and efficient FXa binding and may play a role in stabilizing PS conformation.

摘要

蛋白S(PS)是活化蛋白C(APC)的辅因子,活化蛋白C可使凝血因子(F)Va和VIIIa失活。蛋白C或PS缺乏与血栓形成风险相关。我们发现PS还具有不依赖APC的抗凝活性(PS-直接作用),并直接抑制由FXa/FVa(凝血酶原酶复合物)产生的凝血酶。在此我们报告,PS含有PS-直接作用所需的Zn(2+),且在某些纯化过程中会丢失。免疫亲和纯化的PS含有1.4±0.6 Zn(2+)/mol,而MonoQ纯化的和市售的PS含有0.15±0.15 Zn(2+)/mol。这可能解释了关于PS-直接作用有效性的争议。在凝血酶原酶测定和凝血测定中,Zn(2+)含量与PS-直接作用呈正相关,但PS的APC辅因子活性与Zn(2+)含量无关。在轻度变性条件下,PS-直接作用和Zn(2+)可恢复到无活性的PS。相反,邻菲罗啉可逆地损害活性PS的PS-直接作用。含Zn(2+)的PS比缺乏Zn(2+)的PS更有效地结合FXa(表观解离常数K(d)(app)=9.3 nM)(K(d)(app)=110 nM)。PS有效地结合组织因子途径抑制物(TFPI),与Zn(2+)含量无关(K(d)(app)=21 nM)。阻断PS-直接作用的抗体优先识别含Zn(2+)的PS,表明在PS C末端附近的2个层粘连蛋白G样结构域界面处或其附近存在构象差异。因此,Zn(2+)是PS-直接作用和有效结合FXa所必需的,并且可能在稳定PS构象中起作用。

相似文献

1
Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.血浆蛋白S含有锌,这对于有效的不依赖活化蛋白C的抗凝活性以及与因子Xa的结合是必需的,但对于与组织因子途径抑制剂的有效结合则不是必需的。
FASEB J. 2009 Jul;23(7):2244-53. doi: 10.1096/fj.08-123174. Epub 2009 Feb 24.
2
Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.含 Zn²⁺ 的蛋白质 S 可独立于组织因子途径抑制剂抑制外源性 X 因子激活复合物。
J Thromb Haemost. 2010 Sep;8(9):1976-85. doi: 10.1111/j.1538-7836.2010.03919.x.
3
Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.活化蛋白 C、蛋白 S 和组织因子途径抑制物协同抑制凝血酶的激活。
Thromb Res. 2023 Oct;230:84-93. doi: 10.1016/j.thromres.2023.08.012. Epub 2023 Aug 23.
4
Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.血小板蛋白 S 直接抑制血小板和微颗粒上的促凝活性。
Thromb Haemost. 2013 Feb;109(2):229-37. doi: 10.1160/TH12-08-0622. Epub 2012 Dec 13.
5
Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.血浆蛋白 S 残基 37-50 介导其与因子 Va 的结合并抑制血液凝固。
Thromb Haemost. 2013 Aug;110(2):275-82. doi: 10.1160/TH12-12-0953. Epub 2013 May 23.
6
Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.希尔伦杂合子和正常人中蛋白S-C4b结合蛋白复合物的直接抗凝活性。
J Thromb Haemost. 2004 Oct;2(10):1766-73. doi: 10.1111/j.1538-7836.2004.00901.x.
7
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.新型因子 V 异构体、组织因子途径抑制物α 和蛋白 S 对凝血的调控作用的新见解。
J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665.
8
Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.凝血因子Xa和蛋白S在因子Va中涉及493 - 506位残基的结合位点。
Protein Sci. 1996 Sep;5(9):1883-9. doi: 10.1002/pro.5560050914.
9
Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.蛋白 Z 依赖性蛋白酶抑制剂(ZPI)是凝血酶原酶功能的一种具有生理意义的抑制物。
J Biol Chem. 2019 May 10;294(19):7644-7657. doi: 10.1074/jbc.RA118.006787. Epub 2019 Mar 27.
10
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.因子V具有针对凝血早期阶段的抗凝辅因子活性。
J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

引用本文的文献

1
Relationship between serum zinc level and sepsis-induced coagulopathy.血清锌水平与脓毒症诱导的凝血病之间的关系。
Int J Hematol. 2022 Jan;115(1):87-95. doi: 10.1007/s12185-021-03225-4. Epub 2021 Oct 20.
2
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.抗凝蛋白 S 靶向因子 IXa 肝素结合外显子以预防血栓形成。
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):816-828. doi: 10.1161/ATVBAHA.117.310588. Epub 2018 Feb 1.
3
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.蛋白 S 是血小板和血管内皮组织因子途径抑制剂-α的辅助因子,但不是细胞表面相关组织因子途径抑制剂的辅助因子。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):169-76. doi: 10.1161/ATVBAHA.113.302655. Epub 2013 Nov 14.
4
Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.Zn2+ 介导肝素与纤维蛋白原 αC 结构域的高亲和力结合。
J Biol Chem. 2013 Oct 11;288(41):29394-402. doi: 10.1074/jbc.M113.469916. Epub 2013 Aug 29.
5
Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.血浆蛋白 S 残基 37-50 介导其与因子 Va 的结合并抑制血液凝固。
Thromb Haemost. 2013 Aug;110(2):275-82. doi: 10.1160/TH12-12-0953. Epub 2013 May 23.
6
Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.血小板激酶对蛋白 S 的磷酸化增强了其激活蛋白 C 辅因子活性。
FASEB J. 2013 Jul;27(7):2918-25. doi: 10.1096/fj.12-225961. Epub 2013 Apr 11.
7
Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.血小板蛋白 S 直接抑制血小板和微颗粒上的促凝活性。
Thromb Haemost. 2013 Feb;109(2):229-37. doi: 10.1160/TH12-08-0622. Epub 2012 Dec 13.
8
Protein C anticoagulant and cytoprotective pathways.蛋白 C 抗凝和细胞保护途径。
Int J Hematol. 2012 Apr;95(4):333-45. doi: 10.1007/s12185-012-1059-0. Epub 2012 Apr 5.
9
Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.蛋白 S 输注而无激活蛋白 C 对狒狒血栓模型的抗血栓活性。
Thromb Haemost. 2012 Apr;107(4):690-8. doi: 10.1160/TH11-10-0699. Epub 2012 Feb 28.
10
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂:结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.

本文引用的文献

1
Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.蛋白 S 输注而无激活蛋白 C 对狒狒血栓模型的抗血栓活性。
Thromb Haemost. 2012 Apr;107(4):690-8. doi: 10.1160/TH11-10-0699. Epub 2012 Feb 28.
2
Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.蛋白C或蛋白S的遗传性缺乏会增加年轻时发生动脉血栓栓塞事件的风险:一项大型家系队列研究的结果
Circulation. 2008 Oct 14;118(16):1659-67. doi: 10.1161/CIRCULATIONAHA.108.780759. Epub 2008 Sep 29.
3
The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa.蛋白S的凝血酶敏感区域介导了与凝血因子Xa的磷脂依赖性相互作用。
J Biol Chem. 2008 Nov 28;283(48):33046-52. doi: 10.1074/jbc.M806527200. Epub 2008 Sep 10.
4
Predicting zinc binding at the proteome level.蛋白质组水平上的锌结合预测
BMC Bioinformatics. 2007 Feb 5;8:39. doi: 10.1186/1471-2105-8-39.
5
Plasma contains protein S monomers and multimers with similar direct anticoagulant activity.血浆中含有具有相似直接抗凝活性的蛋白S单体和多聚体。
J Thromb Haemost. 2006 Oct;4(10):2215-22. doi: 10.1111/j.1538-7836.2006.02117.x. Epub 2006 Jul 5.
6
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.对氨基苯甲脒和苯甲脒-VIIa/可溶性组织因子的高分辨率结构:192-193肽键的意外构象以及因子VIIa中Ca2+、Mg2+、Na+和Zn2+位点的定位
J Biol Chem. 2006 Aug 25;281(34):24873-88. doi: 10.1074/jbc.M509971200. Epub 2006 Jun 6.
7
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.蛋白S通过组织因子途径抑制物刺激对组织因子途径的抑制作用。
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11. doi: 10.1073/pnas.0504240103. Epub 2006 Feb 17.
8
Protein S multimers and monomers each have direct anticoagulant activity.蛋白S多聚体和单体均具有直接抗凝活性。
J Thromb Haemost. 2006 Feb;4(2):385-91. doi: 10.1111/j.1538-7836.2006.01743.x.
9
Zinc coordination environments in proteins determine zinc functions.蛋白质中的锌配位环境决定锌的功能。
J Trace Elem Med Biol. 2005;19(1):7-12. doi: 10.1016/j.jtemb.2005.02.003.
10
Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.希尔伦杂合子和正常人中蛋白S-C4b结合蛋白复合物的直接抗凝活性。
J Thromb Haemost. 2004 Oct;2(10):1766-73. doi: 10.1111/j.1538-7836.2004.00901.x.